Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

Rebecca J. Rockett, Alicia Arnott, Connie Lam, +21

Nature Medicine

Rapid Increase in Pertactin-deficient<i>Bordetella pertussis</i>Isolates, Australia

Connie Lam, Sophie Octavia, Lawrence Ricafort, +11

Emerging infectious diseases

VaccinationVaccine DevelopmentBordetella PertussisMedicineZoonotic Disease +13

Population Structure and Evolution of Non-O1/Non-O139 Vibrio cholerae by Multilocus Sequence Typing

Sophie Octavia, Anna C. M. Salim, Jacob Kurniawan, +6

PLoS ONE

Microbial PathogensPathogen DetectionSporadic Cholera IsolatesBacterial PathogensPathogen Biology +19

Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection

Connie Lam, Elena Martínez, Taryn Crighton, +4

International Journal of Infectious Diseases

Evolution of Seventh Cholera Pandemic and Origin of 1991 Epidemic, Latin America

Connie Lam, Sophie Octavia, Peter R. Reeves, +2

Emerging infectious diseases

Seventh Cholera PandemicPathogenesisVibrio CholeraeEpidemiological DynamicThirty Single-nucleotide Polymorphisms +10

Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis

Connie Lam, Sophie Octavia, Zahra Bahrame, +3

Infection Genetics and Evolution

Bordetella PertussisGeneticsPathogenesisMolecular GeneticsGene Expression +1

SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples

Connie Lam, Karen-Ann Gray, Mailie Gall, +9

Journal of Clinical Microbiology

Viral DiagnosticsPathologyGenomicsTheir AbilitiesCovid-19 +15

Multi-locus variable number tandem repeat analysis of 7th pandemic Vibrio cholerae

Connie Lam, Sophie Octavia, Peter R. Reeves, +1

BMC Microbiology

Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose

Kerri Basile, Rebecca J. Rockett, Kenneth McPhie, +16

World Health OrganizationViral DiagnosticsImmunodeficienciesImmunologyViral Pathogenesis +15

Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine

Kerri Basile, Rebecca J. Rockett, Kenneth McPhie, +16

Viruses

World Health OrganizationViral DiagnosticsImmunodeficienciesImmunologyViral Pathogenesis +18